85-4621-49 ［取扱停止］Endothelial-Monocyte A Activating Polypeptide II (EMAP-II), Recombinant, Human 20ug 360177
特徴
- Source:Recombinant protein corresponding to human Endothelial-Monocyte A Activating Polypeptide II, a single non-glycosylated polypeptide chain containing 166aa expressed in E. coli.
- Molecular Weight:~18.3kD (166aa)
- Applications:Suitable for use in SDS-PAGE. Other applications not tested.
- Recommended Dilution:Optimal dilutions to be determined by the researcher.
- Biological Activity:Determined by the apoptotic effect on MCF-7 cells using a concentration of 20-40ng/ml, corresponding to a specific activity of ＞2.5x10e4IU/mg.
- Endotoxin:<1EU/mg (LAL)
- AA Sequence:SKPIDVSRLD LRIGCIITAR KHPDADSLYV EEVDVGEIAP RTVVSGLVNH VPLEQMQNRM VILLCNLKPA KMRGVLSQAM VMCASSPEKI EILAPPNGSV PGDRITFDAF PGEPDKELNP KKKIWEQIQP DLHTNDECVA TYKGVPFEVK GKGVCRAQTM SNSGIK
- Storage and Stability:Lyophilized powder may be stored at -20°C. Reconstitute with sterile dH2O, 0.1% BSA. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
- Size：20ug
- Source Antigen：Recombinant, E. coli
- Grade：Highly Purified
- Purity：~98% (SDS-PAGE, HPLC)
- Form：Supplied as a lyophilized powder in 20mM PB, pH 7.4, 130mM sodium chloride. Reconstitute with sterile dH2O, 0.1% BSA to 0.1-1mg/ml.
- Molecular Weight Non Ab：18.3
- EU Commodity Code：30021019
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
商品のバリエーション （サイズ違い・スペック違い・オプション品など）
よくあるご質問（FAQ）
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|